Key facts
- Value-Based RCM’s last known valuation is $46.0M (Jan 2025).
- It has raised $11.5M across 1 recorded rounds; the latest was Early Stage VC ($11.5M) in Dec 2024.
- Value-Based RCM has filed 1 Form D with the SEC, most recently Jan 2025 ($11.5M sold to 1 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for Value-Based RCM
Funding rounds
1 roundsAbout Value-Based RCM
Developer of a revenue cycle management platform designed to optimize the revenue cycle for anesthesia, substance use disorder, and specialty physicians. The company's platform is focused on cash collections, business support, knowledge transfer and compliance, enabling clients to get customizable data-driven reporting that gets the results an investment deserves.
- Sector
- Information Technology
- HQ
- Homer Glen, IL, United States
- Founded
- 2020
- Employees
- 84
- Website
- vbrcm.com/
- Ownership
- Privately Held (backing)
Value-Based RCM doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Value-Based RCM shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Value-Based RCM in its N-PORT filings yet. We sweep new filings monthly.